Page last updated: 2024-10-21

phenytoin and Primary Myelofibrosis

phenytoin has been researched along with Primary Myelofibrosis in 2 studies

Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.

Research Excerpts

ExcerptRelevanceReference
"Idiopathic myelofibrosis (IM) is a myeloproliferative syndrome characterized by anemia, fibrosis of the bone marrow, variable proliferation of megakaryocytes, myelocytic and erythrocytic precursors, and splenomegaly."1.26Extramedullary blast transformation in the central nervous system in idiopathic myelofibrosis. ( Barnes, HM; Prchal, JT; Scott, CW, 1981)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, HM1
Prchal, JT1
Scott, CW1
Noda, M1
Matsui, K1
Kitagawa, M1
Ohta, M1

Other Studies

2 other studies available for phenytoin and Primary Myelofibrosis

ArticleYear
Extramedullary blast transformation in the central nervous system in idiopathic myelofibrosis.
    American journal of hematology, 1981, Volume: 11, Issue:3

    Topics: Central Nervous System Diseases; Cerebrospinal Fluid; Dexamethasone; Humans; Male; Methotrexate; Mid

1981
Werner's syndrome with myelofibrosis following diphenylhydantoin therapy after meningiomectomy. An autopsy case.
    Journal of the American Geriatrics Society, 1990, Volume: 38, Issue:1

    Topics: Adult; Consanguinity; Humans; Male; Meningeal Neoplasms; Meningioma; Phenytoin; Primary Myelofibrosi

1990